Follow @keithspeights
Recent articles
Canopy Growth Pushes Back Launch of Cannabis Beverages
Here's why the big Canadian cannabis producer's new line of cannabis drinks won't hit shelves in January as planned.
Why Mallinckrodt Stock Is Jumping Today
Momentum from its CEO's comments earlier this week continues.
5 Key Things Investors Should Look Forward to With AbbVie in 2020
The big drugmaker's top executives laid out a vision for AbbVie's future at the J.P. Morgan Healthcare Conference this week.
Why Aurora Cannabis, Charlotte's Web, HEXO, and Sundial Growers Soared Wednesday
Investors are excited about a new CBD bill in the U.S. House of Representatives.
Why Nektar Therapeutics Stock Is Sinking Today
The biotech is throwing in the towel on an experimental painkiller after receiving a thumbs-down from two FDA advisory committees.
Why OrganiGram Holdings Shares Are Crushing It Today
Investors loved what they saw in the Canadian cannabis producer's fiscal 2020 Q1 update.
4 Charts That Show Why You Should Buy Intuitive Surgical Stock
For the leader of robotic surgical systems, the trends are a boost to business prospects.
3 Reasons Organigram Hit a Home Run With Its Q1 Results
The Canadian cannabis producer delivered exactly what investors wanted with its latest quarterly update.
Why Perrigo Shares Are Jumping Today
Investors responded positively to the drugmaker's sneak peek at its Q4 and full-year results.
Why SmileDirectClub Shares Are Soaring Today
The company's battle with former partner Align Technology is heating up.
5 Things in Aphria's Q2 Update More Important Than Its Revenue Miss
Here's what you really need to know about the Canadian cannabis producer's disappointing Q2 results.
Why Canopy Growth, Cronos Group, and Most Other Top Canadian Pot Stocks Are Jumping Today
One exception to the list of big winners: Aurora Cannabis.
Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill
The British drugmaker throws in the towel on a study that could have positioned Epanova to compete against Amarin's Vascepa.
Why Abiomed Shares Are Sinking Today
Abiomed's sneak peek at its Q3 results leaves investors underwhelmed.
Social Security, Warren Buffett, and Marijuana Stocks: How All 3 Fit Into Your Retirement Plans
This seemingly unlikely trio could help you retire in style.
3 High-Yield Dividend Stocks I'd Buy Right Now
A big drugmaker, a global utility company, and an intriguing REIT top my list of great dividend stocks to buy.
Should You Buy Canopy Growth Stock in 2020?
It's volatile. It's risky. But Canopy Growth just might be a big winner this year.
Why Sorrento Therapeutics Stock Is Skyrocketing Today
The third buyout offer in less than two months is lighting a fire beneath this biotech stock.
3 Reasons Why I Just Bought Brookfield Infrastructure Partners Stock
This dividend darling was too attractive to overlook.
Why ADMA Biologics Stock Is Soaring Today
ADMA's sneak peek at its Q4 results and an encouraging 2020 strategic update are exciting investors.